Alternatively, oncolytic virotherapy has also exploited the benefits of IL-15 immunostimulation, with several studies focused on genetically engineered viruses armed with IL-15, either alone or in combination with other molecules, to augment anti-tumor responses [187,188,189,190,191,192]. The gene discussed is IL15; the disease is neoplasm.